Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
61.89
-1.10 (-1.75%)
At close: Mar 9, 2026, 4:00 PM EDT
61.19
-0.70 (-1.13%)
After-hours: Mar 9, 2026, 4:24 PM EDT

Company Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA.

It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.

The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems, Inc.
Inspire Medical Systems logo
Country United States
Founded 2007
IPO Date May 3, 2018
Industry Medical Devices
Sector Healthcare
Employees 1,333
CEO Timothy Herbert

Contact Details

Address:
5500 Wayzata Blvd., Suite 1600
Golden Valley, Minnesota 55416
United States
Phone 844 672 4357
Website inspiresleep.com

Stock Details

Ticker Symbol INSP
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001609550
CUSIP Number 457730109
ISIN Number US4577301090
Employer ID 26-1377674
SIC Code 3841

Key Executives

Name Position
Timothy P. Herbert Founder, Chairman, Chief Executive Officer and President
Bryan K. Phillips J.D. Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary

Latest SEC Filings

Date Type Title
Feb 17, 2026 SCHEDULE 13G/A Filing
Feb 13, 2026 10-K Annual Report
Feb 11, 2026 8-K Current Report
Feb 10, 2026 SCHEDULE 13G Filing
Jan 12, 2026 8-K Current Report
Jan 9, 2026 144 Filing
Dec 2, 2025 144 Filing
Nov 28, 2025 144 Filing
Nov 17, 2025 8-K Current Report
Nov 14, 2025 SCHEDULE 13G/A Filing